Matarin Capital Management’s AbbVie ABBV Stock Holding History

Matarin Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$2.95M	Buy	+27,513	New	+$2.64M	0.72%	57
2020 Q2	–	Sell	-50,372	Closed	-$3.84M	–	191
2020 Q1	$3.84M	Buy	50,372 +4,294	+9%	+$366K	0.6%	79
2019 Q4	$4.08M	Buy	46,078 +3,075	+7%	+$255K	0.39%	121
2019 Q3	$3.26M	Buy	43,003 +935	+2%	+$64.1K	0.25%	146
2019 Q2	$3.06M	Buy	+42,068	New	+$3.31M	0.22%	154
2019 Q1	–	Sell	-37,249	Closed	-$3.43M	–	263
2018 Q4	$3.43M	Sell	37,249 -9,714	-21%	-$854K	0.28%	132
2018 Q3	$4.44M	Buy	46,963 +10,390	+28%	+$985K	0.29%	117
2018 Q2	$3.39M	Sell	36,573 -7,230	-17%	-$706K	0.25%	135
2018 Q1	$4.15M	Sell	43,803 -8,633	-16%	-$948K	0.31%	118
2017 Q4	$5.07M	Buy	52,436 +12,394	+31%	+$1.17M	0.39%	97
2017 Q3	$3.56M	Sell	40,042 -22,659	-36%	-$1.72M	0.3%	134
2017 Q2	$4.55M	Buy	+62,701	New	+$4.22M	0.42%	102
2016 Q4	–	Sell	-88,937	Closed	-$5.61M	–	229
2016 Q3	$5.61M	Buy	+88,937	New	+$5.76M	0.62%	69
2015 Q4	–	Sell	-10,755	Closed	-$585K	–	221
2015 Q3	$585K	Buy	+10,755	New	+$700K	0.12%	172
2015 Q2	–	Sell	-24,572	Closed	-$1.44M	–	193
2015 Q1	$1.44M	Buy	24,572 +8,039	+49%	+$486K	0.44%	112
2014 Q4	$1.08M	Buy	+16,533	New	+$1.04M	0.47%	106

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Matarin Capital Management's ABBV Position: Q4 2020 in Review

Matarin Capital Management opened a new position in AbbVie (ABBV) in Q4 2020: 27,513 shares worth $2.95M. The stake represents 0.72% of the portfolio and ranks #57 among its holdings. This is a return to the name: Matarin Capital Management previously reported a position in ABBV as recently as Q1 2020.

Matarin Capital Management first reported a position in ABBV in Q4 2014 and has held it in 16 quarters since. The position peaked at $5.61M in Q3 2016. 2,599 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

Matarin Capital Management held 27,513 shares of AbbVie worth $2.95M as of Q4 2020.
AbbVie was a new Matarin Capital Management position in Q4 2020.
AbbVie made up 0.72% of Matarin Capital Management's portfolio in Q4 2020, its #57 holding.
Matarin Capital Management first reported a position in AbbVie in Q4 2014 and has held it in 16 quarters since.
Matarin Capital Management's AbbVie position peaked at $5.61M in Q3 2016.
2,599 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Matarin Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.